MLTX
MLTX
NASDAQ · Biotechnology

Moonlake Immunotherapeutics

$11.53
+0.73 (+6.76%)
MLTX vs Biotechnology Average
Profit Margin
MLTX -19.8%
Avg -192.1%
Rev Growth
MLTX +19.2%
Avg +12.8%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
MLTX Moonlake Immunotherapeutics $11.53 +6.76% 981.28M — -19.8% +19.2% — Current
ABBV Abbvie Inc $293.30 +0.68% 509.50B 49.3 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $465.23 +1.04% 248.84B 26.5 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $169.32 +1.46% 208.28B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $550.87 +0.69% 137.12B 34.5 32.9% +10.4% — Strong buy Compare
MRNA Moderna Inc $269.00 +5.83% 105.54B — -145.2% -53.4% — Hold Compare
REGN Regeneron Pharmaceuticals $919.96 +1.73% 93.39B 19.4 31.4% +5.6% — Buy Compare
NTRA Natera Inc $320.39 +3.13% 45.18B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $200.15 +4.09% 41.37B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $254.87 +2.63% 36.60B 43.9 13.1% -0.9% — Buy Compare
ROIV Roivant Sciences Ltd $40.67 +4.60% 28.08B — -3,629.2% -48.7% — Strong buy Compare
UTHR United Therapeutics Corp $582.46 +3.64% 24.27B 18.5 41.9% +18.0% — Strong buy Compare
INCY Incyte Corp $121.89 +1.87% 24.22B 15.0 25.0% +14.8% — Hold Compare
INSM Insmed Inc $116.10 +1.48% 23.86B — -210.5% +35.2% — Strong buy Compare
ALNY Alnylam Pharmaceuticals Inc $156.61 +0.43% 20.98B 7.7 8.5% +53.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
EXEL Exelixis Inc $71.74 +3.12% 16.67B 18.8 33.7% +12.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $168.86 +2.57% 16.41B 23.3 16.7% +24.3% — Strong buy Compare
BBIO Bridgebio Pharma Inc $77.93 +4.90% 14.51B — -144.4% +86.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $102.92 -0.69% 13.96B 33.7 22.7% +28.4% — Strong buy Compare
SMMT Summit Therapeutics Inc $17.84 +9.25% 12.69B — 15.4% -3.6% — Buy Compare